BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10806593)

  • 1. Primer system for single cell detection of double mutation for Tay-Sachs disease.
    Liu MC; Drury KC; Kipersztok S; Zheng W; Williams RS
    J Assist Reprod Genet; 2000 Feb; 17(2):121-6. PubMed ID: 10806593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten novel mutations in the HEXA gene in non-Jewish Tay-Sachs patients.
    Akli S; Chomel JC; Lacorte JM; Bachner L; Kahn A; Poenaru L
    Hum Mol Genet; 1993 Jan; 2(1):61-7. PubMed ID: 8490625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation common in non-Jewish Tay-Sachs disease: frequency and RNA studies.
    Akerman BR; Zielenski J; Triggs-Raine BL; Prence EM; Natowicz MR; Lim-Steele JS; Kaback MM; Mules EH; Thomas GH; Clarke JT
    Hum Mutat; 1992; 1(4):303-9. PubMed ID: 1301938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.
    Myerowitz R
    Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A chronic GM2 gangliosidosis variant with a HEXA splicing defect: quantitation of HEXA mRNAs in normal and mutant fibroblasts.
    Fernandes MJ; Hechtman P; Boulay B; Kaplan F
    Eur J Hum Genet; 1997; 5(3):129-36. PubMed ID: 9272736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase.
    Myerowitz R; Costigan FC
    J Biol Chem; 1988 Dec; 263(35):18587-9. PubMed ID: 2848800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and mutational analyses of HEXA in a cohort of Egyptian patients with infantile Tay-Sachs disease. Expansion of the mutation spectrum.
    Ibrahim DMA; Ali OSM; Nasr H; Fateen E; AbdelAleem A
    Orphanet J Rare Dis; 2023 Mar; 18(1):52. PubMed ID: 36907859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease.
    Akli S; Chelly J; Mezard C; Gandy S; Kahn A; Poenaru L
    J Biol Chem; 1990 May; 265(13):7324-30. PubMed ID: 2139660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence of DNA flanking the exons of the HEXA gene, and identification of mutations in Tay-Sachs disease.
    Triggs-Raine BL; Akerman BR; Clarke JT; Gravel RA
    Am J Hum Genet; 1991 Nov; 49(5):1041-54. PubMed ID: 1833974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to respond to polymerase chain reaction deoxyribonucleic acid amplification failure in a preimplantation genetic diagnosis program.
    Gibbons WE; Gitlin SA; Lanzendorf SE
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1088-95; discussion 1095-6. PubMed ID: 7726246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A glycine250--> aspartate substitution in the alpha-subunit of hexosaminidase A causes juvenile-onset Tay-Sachs disease in a Lebanese-Canadian family.
    Trop I; Kaplan F; Brown C; Mahuran D; Hechtman P
    Hum Mutat; 1992; 1(1):35-9. PubMed ID: 1301189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A splicing defect due to an exon-intron junctional mutation results in abnormal beta-hexosaminidase alpha chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease.
    Ohno K; Suzuki K
    Biochem Biophys Res Commun; 1988 May; 153(1):463-9. PubMed ID: 2837213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of the Tay-Sachs disease splice and insertion mutations in the UK Ashkenazi Jewish population.
    Landels EC; Ellis IH; Fensom AH; Green PM; Bobrow M
    J Med Genet; 1991 Mar; 28(3):177-80. PubMed ID: 1828838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.
    Triggs-Raine BL; Mules EH; Kaback MM; Lim-Steele JS; Dowling CE; Akerman BR; Natowicz MR; Grebner EE; Navon R; Welch JP
    Am J Hum Genet; 1992 Oct; 51(4):793-801. PubMed ID: 1384323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Tay-Sachs disease mutations from China.
    Akalin N; Shi HP; Vavougios G; Hechtman P; Lo W; Scriver CR; Mahuran D; Kaplan F
    Hum Mutat; 1992; 1(1):40-6. PubMed ID: 1301190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intron 7 donor splice site transition: a second Tay-Sachs disease mutation in French Canada.
    Hechtman P; Boulay B; De Braekeleer M; Andermann E; Melançon S; Larochelle J; Prevost C; Kaplan F
    Hum Genet; 1992 Dec; 90(4):402-6. PubMed ID: 1483696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of enzyme and DNA analysis in a Tay-Sachs disease carrier screening program.
    Yoo HW; Astrin KH; Desnick RJ
    J Korean Med Sci; 1993 Feb; 8(1):84-91. PubMed ID: 8343225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-hexosaminidase splice site mutation has a high frequency among non-Jewish Tay-Sachs disease carriers from the British Isles.
    Landels EC; Green PM; Ellis IH; Fensom AH; Bobrow M
    J Med Genet; 1992 Aug; 29(8):563-7. PubMed ID: 1387685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An A-to-G mutation at the +3 position of intron 8 of the HEXA gene is associated with exon 8 skipping and Tay-Sachs disease.
    Richard MM; Erenberg G; Triggs-Raine BL
    Biochem Mol Med; 1995 Jun; 55(1):74-6. PubMed ID: 7551830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments.
    Akli S; Chelly J; Lacorte JM; Poenaru L; Kahn A
    Genomics; 1991 Sep; 11(1):124-34. PubMed ID: 1837283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.